Given our analysis of clinical specimens suggested a connection between MSI2 expression, E-cadherin/CDH1 expression, and tumor grade, particularly in tumor metastases, we analyzed whether MSI2 might directly regulate E-cadherin expression in CRC. The gene discussed is CDH1; the disease is neoplasm.